Articles From: Chevron discovers new oil in deepwater Gulf to Pfizer: FDA Not Planning Meeting Yet For Breast-Cancer Drug


2015/1/6
By Angela Chen Chevron Corp.
Sign-up for Chevron discovers new oil in deepwater Gulf investment picks
2014/12/16
By Angela Chen Chrysler Group becomes FCA US Auto maker Chrysler Group LLC has changed its company name to FCA US LLC, marking the end for one of the more iconic corporate automobile names in the U.S. The move, effective immediately, follows the naming convention of parent company Fiat Chrysler Automobiles NV(FCAU) , which made its debut on the New York Stock Exchange in October.
Sign-up for Chrysler disappears in company name change investment picks
By Angela Chen Del Monte Fresh Produce Inc. (FDP) is voluntarily recalling more than 3,000 fruit packages that may be contaminated with a bacteria that causes serious, and sometimes fatal, infections.
Sign-up for Del Monte recalls 3,000 fruit packages investment picks
2015/1/12
By Angela Chen DuPont Co.
Sign-up for DuPont to Sell Theater Business Amid Criticism From Activists investment picks
2014/12/29
By Angela Chen Food-ingredient producers Ingredion Inc. and Penford Corp.
Sign-up for Justice Department Seeks More Information on Ingredion-Penford Deal investment picks
By Angela Chen Gilead Sciences Inc. will allow a subsidiary of the pharmaceutical company Mylan Inc. to have nonexclusive rights to manufacture and distribute its HIV treatment drug in 112 countries.
Sign-up for Mylan to manufacture, distribute Gilead Sciences HIV drug investment picks
2015/1/8
By Angela Chen Global Payments Inc. said its revenue rose 10% in the November-ended quarter as the electronics-payments company continues to look at possible acquisitions and expand into the Asian market.
Sign-up for Global Payments Profit, Revenue Rise investment picks
2014/12/19
By Angela Chen Goldman Sachs Group Inc. has appointed Mark O.
Sign-up for Goldman Sachs Adds 2 to Board, Total Now 14 investment picks
2014/12/16
By Angela Chen Google Inc. and Verizon Communications Inc. have entered a long-term patent cross-license agreement to reduce the risk of future patent lawsuits.
Sign-up for Google, Verizon Enter Patent Agreement investment picks
2014/11/17
By Angela Chen Halliburton Co.
Sign-up for Halliburton to acquire Baker Hughes in $34.6 billion deal investment picks
2015/1/8
By Angela Chen Infinity Pharmaceuticals Inc. won't continue developing its rheumatoid-arthritis treatment after the drug, called duvelisib, didn't meet its goal in a clinical trial.
Sign-up for Infinity to stop development of rheumatoid-arthritis treatment investment picks
2014/12/3
By Angela Chen Intel Corp.
Sign-up for Intel to make smart eyewear with Luxottica investment picks
By Angela Chen Intuitive Surgical Inc. (ISRG) projected a better-than-expected revenue increase of 5% for the fourth quarter, citing an increase in procedures using its robotic surgical systems.
Sign-up for Intuitive Surgical Sees Better-Than-Expected Revenue Jump investment picks
By Angela Chen Lear Corp.
Sign-up for Lear earnings climb 24%, buoyed by China and North America investment picks
2014/12/18
By Angela Chen Merck & Co.
Sign-up for Merck Acquires OncoEthix for Up to $375 Million investment picks
By Angela Chen MetLife Inc. (MET) on Tuesday said it will provide pension benefits for the beneficiaries of a TRW Automotive Holdings Corp.
Sign-up for MetLife, TRW Sign $440 Million Pension Buyout Agreement investment picks
2014/12/18
By Angela Chen Move continues push into the oncology market for pharmaceutical giant Merck & Co.
Sign-up for Merck acquires OncoEthix for up to $375 million investment picks
2015/1/5
By Angela Chen Nasdaq OMX Group Inc. agreed to acquire index provider and analytics group Dorsey, Wright & Associates LLC for $225 million, as the exchange operator expands its exchange-traded fund and so-called smart-beta indexing segments to diversify its business.
Sign-up for Nasdaq to buy Dorsey Wright for $225 million investment picks
By Angela Chen OPKO will get upfront payment of $295 million and is eligible for up to $275 million more Pfizer Inc. and OPKO Health Inc. have partnered to develop and commercialize an OPKO treatment for growth-hormone deficiency that could replace daily injections with weekly ones.
Sign-up for Pfizer, OPKO Health partner on growth-hormone treatment investment picks
2014/12/19
By Angela Chen Paychex Inc. said higher revenue thanks to a new health-insurance product in its human-resources segment helped drive results in the second quarter, a sign the company's strategy to diversify its service offerings is paying off.
Sign-up for Paychex Earnings Grow on Strength of New Products investment picks
By Angela Chen Perfect World Co.
Sign-up for Perfect World gets buyout offer from chairman investment picks
By Angela Chen Petroleum company Harvest Natural Resources Inc. said its deal to exit its operations in Venezuela has been terminated after the country's government failed to approve the plan by the end of December.
Sign-up for Harvest Natural terminates plan to exit Venezuela operations investment picks
2015/1/5
By Angela Chen Pfizer Inc. has acquired a controlling interest in privately held Redvax GmbH, a move that gives the increasingly vaccine-focused drug giant access to a potential vaccine against a herpes virus.
Sign-up for Pfizer Acquires Redvax for its Potential Herpes Vaccine investment picks
By Angela Chen Pfizer Inc. has acquired a controlling interest in privately held Redvax GmbH, a move that gives the increasingly vaccine-focused drug giant access to a potential vaccine against a herpes virus.
Sign-up for Pfizer acquires Redvax for its potential herpes vaccine investment picks
2015/1/12
By Angela Chen Proposed merger values combined company at about $750 million Tekmira Pharmaceuticals Corp.
Sign-up for Tekmira to buy OnCore, creating Hepatitis B-focused 'powerhouse' investment picks
2014/12/16
By Angela Chen Steelmaker Nucor Corp.
Sign-up for Nucor Offers Disappointing Outlook Tied to Louisiana Equipment Failure investment picks
2015/1/9
By Angela Chen Supercomputer company Cray Inc. warned that it would miss targets for 2014 because it was unable to deliver on all of its late-year contracts.
Sign-up for Cray says delayed contracts to hurt 2014 results, help 2015 investment picks
By Angela Chen T-Mobile US Inc. on Wednesday said it added 1.3 million branded postpaid customers--the most lucrative type of wireless subscribers--in the fourth quarter, the vast majority of whom were phone customers.
Sign-up for T-Mobile US posts strong fourth-quarter subscriber growth investment picks
2014/12/12
By Angela Chen The U.S. Food and Drug Administration has approved Eli Lilly Co.'s Cyramza to treat non-small cell lung cancer, the most common type of lung cancer.
Sign-up for FDA approves Eli Lilly's Cyramza for lung cancer investment picks
2015/1/8
By Angela Chen The U.S. Food and Drug Administration isn't planning an advisory committee meeting at this time to evaluate Pfizer Inc.'s experimental breast-cancer treatment, despite the drug having received priority-review status in October, the company said Thursday.
Sign-up for Pfizer: FDA Not Planning Meeting Yet For Breast-Cancer Drug investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Chevron discovers new oil in deepwater Gulf to Pfizer: FDA Not Planning Meeting Yet For Breast-Cancer Drug
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent